File(s) under permanent embargo
Validation of linear cerebral atrophy markers in multiple sclerosis
journal contribution
posted on 2023-05-26, 16:00 authored by Butzkueven, H, Kolbe, SC, Jolley, DJ, Brown, JY, Cook, MJ, Ingrid van der MeiIngrid van der Mei, Groom, PS, Carey, J, Eckholdt, J, Rubio, JP, Bruce TaylorBruce Taylor, Mitchell, PJ, Egan, GF, Kilpatrick, TJLinear measures of cerebral ventricular enlargement may act as surrogate measures of cerebral atrophy in multiple sclerosis (MS). Linear atrophy markers were measured from routine MRI scans during a population survey of 171 Tasmanian MS patients and 91 healthy controls. Thirty-five Victorian MS clinic patients were recruited as a validation cohort with 14 of these re-assessed 4 years later. In the population survey, we measured three linear brain atrophy markers: inter-caudate distance (ICD), third ventricle width (TVW) and frontal horn width (FHW). TVW (OR 2.0, p=0.001) and ICD (OR 16.1, p<0.001) differentiated between MS cases and controls. In the validation study, we correlated the intercaudate ratio (ICR=ICD/brain width) and third ventricular ratio (TVR=TVW/brain width) with brain parenchymal volume. Cross-sectionally, ICR (R=-0.453, p<0.01) and TVR (R=-0.653, p<0.01) were correlated with brain parenchymal volume. Longitudinally, brain parenchymal volume loss was inversely correlated with increased ICD (R=-0.77, p<0.01) and TVW (R=-0.71, p<0.01). This study shows that ICD measurements obtained from clinical MRI scans are valid brain atrophy measures for use in monitoring MS progression.
History
Publication title
Journal of Clinical NeuroscienceVolume
15Article number
2Number
2Pagination
130-137Department/School
School of ComputingPublication status
- Published
Rights statement
The definitive version is available at http://www.sciencedirect.comRepository Status
- Restricted
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC